Arden Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $3.41M | Sell |
27,561
-163
| -0.6% | -$21K | 0.48% | 40 |
|
|
2024
Q1 | $3.66M | Sell |
27,724
-775
| -3% | -$95.5K | 0.51% | 38 |
|
|
2023
Q4 | $3.11M | Sell |
28,499
-558
| -2% | -$57.9K | 0.46% | 40 |
|
|
2023
Q3 | $2.99M | Sell |
29,057
-2,278
| -7% | -$246K | 0.5% | 40 |
|
|
2023
Q2 | $3.62M | Sell |
31,335
-5,841
| -16% | -$663K | 0.59% | 35 |
|
|
2023
Q1 | $3.96M | Sell |
37,176
-6,098
| -14% | -$658K | 0.71% | 35 |
|
|
2022
Q4 | $4.8M | Sell |
43,274
-697
| -2% | -$71.2K | 0.98% | 18 |
|
|
2022
Q3 | $3.79M | Sell |
43,971
-3,411
| -7% | -$305K | 0.96% | 22 |
|
|
2022
Q2 | $4.32M | Sell |
47,382
-3,725
| -7% | -$330K | 0.99% | 17 |
|
|
2022
Q1 | $4.19M | Sell |
51,107
-2,734
| -5% | -$216K | 0.82% | 26 |
|
|
2021
Q4 | $4.13M | Sell |
53,841
-9,481
| -15% | -$755K | 0.7% | 28 |
|
|
2021
Q3 | $4.76M | Buy |
63,322
+315
| +0.5% | +$24K | 0.81% | 18 |
|
|
2021
Q2 | $4.9M | Sell |
63,007
-5,259
| -8% | -$391K | 0.8% | 18 |
|
|
2021
Q1 | $5.02M | Sell |
68,266
-100
| -0.1% | -$7.38K | 0.85% | 18 |
|
|
2020
Q4 | $5.34M | Sell |
68,366
-10,191
| -13% | -$779K | 0.89% | 19 |
|
|
2020
Q3 | $6.22M | Sell |
78,557
-4,540
| -5% | -$356K | 1.12% | 15 |
|
|
2020
Q2 | $6.13M | Buy |
83,097
+1,311
| +2% | +$98.7K | 1.13% | 15 |
|
|
2020
Q1 | $6M | Sell |
81,786
-1,256
| -2% | -$98.7K | 1.2% | 13 |
|
|
2019
Q4 | $7.21M | Sell |
83,042
-4,764
| -5% | -$391K | 1.13% | 16 |
|
|
2019
Q3 | $7.05M | Sell |
87,806
-598
| -0.7% | -$47.9K | 1.15% | 13 |
|
|
2019
Q2 | $7.07M | Sell |
88,404
-1,482
| -2% | -$113K | 1.19% | 11 |
|
|
2019
Q1 | $7.13M | Sell |
89,886
-4,119
| -4% | -$308K | 1.15% | 11 |
|
|
2018
Q4 | $6.85M | Sell |
94,005
-5,857
| -6% | -$413K | 1.23% | 10 |
|
|
2018
Q3 | $6.76M | Sell |
99,862
-498
| -0.5% | -$31.7K | 1.05% | 13 |
|
|
2018
Q2 | $5.81M | Sell |
100,360
-6,223
| -6% | -$351K | 0.92% | 16 |
|
|
2018
Q1 | $5.54M | Sell |
106,583
-2,380
| -2% | -$129K | 0.86% | 16 |
|
|
2017
Q4 | $5.85M | Sell |
108,963
-877
| -0.8% | -$48.6K | 0.89% | 17 |
|
|
2017
Q3 | $6.71M | Sell |
109,840
-2,168
| -2% | -$131K | 1.02% | 14 |
|
|
2017
Q2 | $6.85M | Sell |
112,008
-1,700
| -1% | -$103K | 1.05% | 14 |
|
|
2017
Q1 | $6.89M | Buy |
113,708
+877
| +0.8% | +$53.2K | 1.08% | 15 |
|
|
2016
Q4 | $6.34M | Sell |
112,831
-6,119
| -5% | -$358K | 0.96% | 18 |
|
|
2016
Q3 | $7.08M | Sell |
118,950
-127,333
| -52% | -$7.45M | 1.09% | 12 |
|
|
2016
Q2 | $13.5K | Buy |
246,283
+4,094
| +2% | +$218K | 1.02% | 21 |
|
|
2016
Q1 | $12.2M | Sell |
242,189
-6,127
| -2% | -$300K | 0.98% | 21 |
|
|
2015
Q4 | $12.5M | Buy |
248,316
+13,566
| +6% | +$684K | 1.05% | 16 |
|
|
2015
Q3 | $11.1M | Buy |
234,750
+76,627
| +48% | +$4.07M | 0.91% | 18 |
|
|
2015
Q2 | $8.59K | Sell |
158,123
-220
| -0.1% | -$12.3K | 1.29% | 14 |
|
|
2015
Q1 | $8.68K | Buy |
158,343
+38,945
| +33% | +$2.21M | 1.26% | 13 |
|
|
2014
Q4 | $6.47M | Sell |
119,398
-3,995
| -3% | -$223K | 0.89% | 18 |
|
|
2014
Q3 | $6.98M | Sell |
123,393
-2,666
| -2% | -$150K | 0.96% | 15 |
|
|
2014
Q2 | $6.96M | Sell |
126,059
-4,488
| -3% | -$245K | 0.95% | 15 |
|
|
2014
Q1 | $7.07M | Sell |
130,547
-8,151
| -6% | -$422K | 0.87% | 17 |
|
|
2013
Q4 | $6.62M | Sell |
138,698
-1,278
| -0.9% | -$58.4K | 0.8% | 19 |
|
|
2013
Q3 | $6.36M | Sell |
139,976
-6,636
| -5% | -$303K | 0.81% | 18 |
|
|
2013
Q2 | $6.5M | Buy |
+146,612
| New | +$6.55M | 0.79% | 17 |
|
Other funds holding MRK
Arden Trust's MRK Position: Q2 2024 in Review
Arden Trust reduced its Merck (MRK) stake by 0.59% in Q2 2024, selling an estimated $21K and leaving 27,561 shares worth $3.41M. The position accounts for 0.48% of the portfolio, ranked #40.
Arden Trust first reported a position in MRK in Q2 2013 and has held it in 45 quarters since. The position peaked at $12.5M in Q4 2015. 3,544 funds tracked by Wall St. Rank hold MRK as of Q2 2024.
- Arden Trust held 27,561 shares of Merck worth $3.41M as of Q2 2024.
- Arden Trust sold 163 Merck shares in Q2 2024, an estimated $21K.
- Merck made up 0.48% of Arden Trust's portfolio in Q2 2024, its #40 holding.
- Arden Trust first reported a position in Merck in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Merck position peaked at $12.5M in Q4 2015.
- 3,544 funds tracked by Wall St. Rank held Merck as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.